文献速递皮肤肿瘤

皮肤科随访与黑色素瘤生存的关联:基于人群的队列研究

Association between dermatology follow-up and melanoma survival: A population-based cohort study.
PubMed 文献 · J Am Acad Dermatol · 2024-02-16

该回顾性队列研究纳入加拿大安大略省2010至2013年诊断为原发性浸润性黑色素瘤的成人,随访至2018年底,评估每年皮肤科随访的依从性及其与黑色素瘤特异性死亡率的关系。仅28.0%的患者至少每年看一次皮肤科医生,更高的随访依从性与黑色素瘤特异性死亡率降低相关(调整后风险比0.64,95%CI 0.52-0.78)。

要点

  • 黑色素瘤诊断后每年皮肤科随访的依从性低,仅28.0%患者达标。
  • 更高随访依从性与黑色素瘤特异性死亡率降低相关(调整后HR 0.64)。
  • 年轻、女性、高收入、更多皮肤科资源、2/3期黑色素瘤等预测更好依从性。

核心结论

  • 黑色素瘤诊断后每年皮肤科随访的依从性低,仅28.0%患者至少每年看一次皮肤科医生(中位随访5.0年)。
  • 更高的年度皮肤科随访依从性与黑色素瘤特异性死亡率降低相关(调整后风险比0.64,95%CI 0.52-0.78)。

研究设计与样本

  • 回顾性起始队列分析,纳入加拿大安大略省2010至2013年诊断的原发性浸润性黑色素瘤成人,随访至2018年12月31日。

主要发现

  • 仅28.0%患者至少每年看一次皮肤科医生(中位随访5.0年)。
  • 年轻年龄、女性、更高收入、更多皮肤科诊疗可及性、2/3期黑色素瘤、既往角质形成细胞癌、更少合并症、诊断前12个月内任何门诊就诊是依从性的预测因素。
  • 更高依从性与黑色素瘤特异性死亡率降低相关(调整后风险比0.64,95%CI 0.52-0.78)。

临床怎么用

  • 指南推荐黑色素瘤患者至少每年进行皮肤科检查,但实际依从性低,需关注提高随访依从性以可能改善生存。

局限性

  • 观察性研究设计,无法识别非皮肤科医生进行的皮肤检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Guidelines recommend that patients with melanoma undergo dermatologic examination at least annually. Adherence to follow-up and its impact on survival are unclear. OBJECTIVE: To determine the level of adherence to annual dermatologic follow-up in patients with primary cutaneous melanoma, identify predictors for better adherence, and evaluate whether adherence was associated with melanoma-related mortality. METHODS: Retrospective inception cohort analysis of adults with primary invasive melanoma in Ontario, Canada from 2010 to 2013 with follow-up until December 31, 2018. RESULTS: Adherence to dermatologic follow-up was variable with only 28.0% of patients seeing a dermatologist at least annually (median follow-up 5.0 years). Younger age, female sex, higher income, greater access to dermatology care, stage 2/3 melanoma, prior keratinocyte carcinoma, fewer comorbidities, and any outpatient visit in the 12 months prior to melanoma diagnosis were predictors for adherence. Greater adherence to annual dermatology visits was associated with reduced melanoma-specific mortality compared with lower levels of adherence (adjusted hazard ratio 0.64, 95% CI 0.52-0.78). LIMITATIONS: Observational study design and inability to identify skin examinations performed by non-dermatologists. CONCLUSION: Adherence to annual dermatology visits after melanoma diagnosis was low. Greater adherence may promote better patient survival but warrants confirmation in further research including randomized trials.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Huang Y, Fleming P, Fung K, et al. Association between dermatology follow-up and melanoma survival: A population-based cohort study. J Am Acad Dermatol. 2024. PMID: 38368952. doi:10.1016/j.jaad.2024.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。